Pathogenesis and treatment of immune-mediated neuropathies. - Wikidata - wikimedia - TriplyDB

Pathogenesis and treatment of immune-mediated neuropathies.

Pathogenesis and treatment of immune-mediated neuropathies.

http://www.wikidata.org/entity/Q34409385

about

Neurofascin as a target for autoantibodies in peripheral neuropathies.Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).Novel treatment for immune neuropathies on the horizon.Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.Treatment-related Fluctuations in Guillain Barre Syndrome and the Conundrum of Additional Cycles of Plasmapheresis.Associated conditions in small fiber neuropathy - a large cohort study and review of the literature.Immune-mediated Neuropathies Our Experience over 3 Years.Immune-mediated Neuropathies Our Experience over 3 Years.Differenzialdiagnose von Erkrankungen des Plexus brachialis

P2860

Q36524437-D10CC1AF-7EE3-4CE0-BC23-1D68271BA719 Q37291772-B86294E6-3C30-4F79-94FA-90696F13AEB5 Q37892641-B4EC38F8-3386-4ED5-AA73-8092BF82655A Q41450051-8B082FCD-7148-4249-BFE4-440FAA49EA2C Q47105292-2D65A3A0-8EE0-4D5A-A47C-E028C964B652 Q47578766-E6C2E15C-7331-4B59-A5DE-9A639D6848A5 Q49528901-D80EC233-3BD1-4C4D-A30F-58BF4EDC6895 Q49885763-80C170C5-1419-4C07-B120-0A9550A59D4D Q57514502-BEA9A534-6501-479D-9FD9-529CCCEB9491

P2860

Pathogenesis and treatment of immune-mediated neuropathies.

http://www.wikidata.org/entity/Q34409385

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pathogenesis and treatment of immune-mediated neuropathies.

@ast

Pathogenesis and treatment of immune-mediated neuropathies.

@en

Pathogenesis and treatment of immune-mediated neuropathies.

@nl

type

label

Pathogenesis and treatment of immune-mediated neuropathies.

@ast

Pathogenesis and treatment of immune-mediated neuropathies.

@en

Pathogenesis and treatment of immune-mediated neuropathies.

@nl

prefLabel

Pathogenesis and treatment of immune-mediated neuropathies.

@ast

Pathogenesis and treatment of immune-mediated neuropathies.

@en

Pathogenesis and treatment of immune-mediated neuropathies.

@nl

P1433

Q34409385-9019D0F8-7DF5-4665-AA05-A97D335EED77

P1476

Q34409385-4E111C48-C002-4AEF-995D-E55972BBFDBE

P2093

Q34409385-798F8D0A-86C0-4806-A92F-DBAEF41B6BC2

Q34409385-D08FD8F7-AC4B-4E0A-961B-E1AE86E944AF

P2860

Q34409385-01ADC104-8056-4F90-A88B-92D58506BCE9

Q34409385-0733C39E-3E8C-4A60-BF79-2C6296D7645C

Q34409385-073EEBAB-19A0-49FC-B765-4F5A9546EB00

Q34409385-0DA37CCA-3FE0-4648-8429-21D7981E5B73

Q34409385-1127FC6B-C77B-4A0C-A000-D345A92EC78C

Q34409385-11EFA610-4649-4E50-B2AB-2F7E63411FDB

Q34409385-147E334E-1133-4314-BAEB-E53F6324D4BA

Q34409385-19C243A5-3FCB-4FA8-A130-957EA86D663E

Q34409385-1D88AF99-5E3B-46A6-8E64-8FF1BDB8988E

Q34409385-1E70E279-34EE-4774-9335-C6A6C96411BB

P304

Q34409385-A9700F36-1282-45CA-A23C-AEC04DCD5A3B

P31

Q34409385-2f28840d-a13a-4707-be50-c7c84f41aa75

Q34409385-CAC9F472-BCAE-4E49-840C-D57D15250DAF

P356

Q34409385-5A6E704A-A813-4E00-9F4D-C7AD3C67113E

P433

Q34409385-29097C9F-5800-4433-8E9A-E74D4FDFFCAB

P478

Q34409385-24C1EDCF-93B9-4C66-8E8D-B5392F98A2E3

P50

Q34409385-2814C402-5D07-4449-B7CC-A2DD324874B2

Q34409385-E3F85630-0AF1-4081-B1B6-17B216433499

P577

Q34409385-46FD62D5-003D-49A8-96FC-B8E5CE281EBE

P5875

Q34409385-7843AB8B-0459-4BAF-9906-76A4CB5A88CC

P698

Q34409385-07AF369B-2294-445D-94D2-1ACFC59C4C84

P932

Q34409385-760E5B26-9A3B-43E9-A4AB-E3BD7CDE5AA9

P356

1756285609104792

P1433

Therapeutic advances in neurological disorders

P1476

Pathogenesis and treatment of immune-mediated neuropathies.

@en

P2093

Gerd Meyer Zu Horste

http://www.w3.org/2001/XMLSchema#string

Helmar C Lehmann

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

Immunotherapy for Guillain-Barre syndrome: a systematic review

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies

Intravenous immunoglobulin for Guillain-Barré syndrome

Treatment for IgG and IgA paraproteinaemic neuropathy

Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies

Guillain-Barré syndrome

Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

Different ceramide compositions of gangliosides between human motor and sensory nerves

P304

261-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756285609104792

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Peter Hartung

Bernd C Kieseier

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49703513

http://www.w3.org/2001/XMLSchema#string

P698

21179533

http://www.w3.org/2001/XMLSchema#string

P932

3002632

http://www.w3.org/2001/XMLSchema#string